Global Endowment Management LP Holds Position in Clorox Company (The) (NYSE:CLX)

Global Endowment Management LP continued to hold its stake in Clorox Company (The) (NYSE:CLX) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,450 shares of the company’s stock at the end of the first quarter. Global Endowment Management LP’s holdings in Clorox Company (The) were worth $330,000 as of its most recent filing with the SEC.

Other hedge funds also recently added to or reduced their stakes in the company. Parnassus Investments CA bought a new stake in Clorox Company (The) during the first quarter worth about $434,255,000. Vanguard Group Inc. raised its stake in Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock worth $1,909,829,000 after buying an additional 649,766 shares during the last quarter. WINTON GROUP Ltd raised its stake in Clorox Company (The) by 762.4% in the first quarter. WINTON GROUP Ltd now owns 228,197 shares of the company’s stock worth $28,566,000 after buying an additional 201,737 shares during the last quarter. Korea Investment CORP raised its stake in Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock worth $24,026,000 after buying an additional 161,044 shares during the last quarter. Finally, BNP Paribas Arbitrage SA raised its stake in Clorox Company (The) by 228.7% in the first quarter. BNP Paribas Arbitrage SA now owns 193,035 shares of the company’s stock worth $26,027,000 after buying an additional 134,316 shares during the last quarter. Institutional investors own 70.75% of the company’s stock.

Shares of Clorox Company (CLX) traded up 1.03% during midday trading on Friday, reaching $132.24. The company had a trading volume of 564,488 shares. The stock has a 50-day moving average of $135.68 and a 200 day moving average of $132.27. The firm has a market capitalization of $17.03 billion, a price-to-earnings ratio of 26.12 and a beta of 0.40. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Wednesday, May 3rd. The company reported $1.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.01. Clorox Company (The) had a return on equity of 215.99% and a net margin of 11.22%. The business had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same quarter in the previous year, the business earned $1.21 earnings per share. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, analysts anticipate that Clorox Company will post $5.31 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 4th. Shareholders of record on Wednesday, July 19th will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 2.54%. The ex-dividend date of this dividend is Monday, July 17th. This is a positive change from Clorox Company (The)’s previous quarterly dividend of $0.80. Clorox Company (The)’s payout ratio is 66.27%.

TRADEMARK VIOLATION WARNING: “Global Endowment Management LP Holds Position in Clorox Company (The) (NYSE:CLX)” was reported by BBNS and is owned by of BBNS. If you are viewing this article on another domain, it was illegally copied and republished in violation of international copyright legislation. The correct version of this article can be accessed at https://baseballnewssource.com/markets/global-endowment-management-lp-has-330000-position-in-clorox-company-the-nyseclx-updated/1180349.html.

CLX has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $151.00 target price on the stock in a research note on Wednesday, April 5th. Vetr upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 target price on the stock in a research note on Monday, April 24th. Jefferies Group LLC initiated coverage on Clorox Company (The) in a research note on Tuesday, April 18th. They issued a “hold” rating and a $138.00 target price on the stock. BMO Capital Markets restated a “buy” rating and issued a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Finally, Royal Bank Of Canada restated a “hold” rating and issued a $115.00 target price on shares of Clorox Company (The) in a research note on Friday, June 30th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $128.26.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with our FREE daily email newsletter.

 


Latest News

Chris Sale Reaches 200 Strikeouts in Record Time
Chris Sale Reaches 200 Strikeouts in Record Time
Veteran Pitcher Bartolo Colon Considering Retirement
Veteran Pitcher Bartolo Colon Considering Retirement
Todd Frazier Traded to Yankees for Blake Rutherford and Others
Todd Frazier Traded to Yankees for Blake Rutherford and Others
Tigers Would Include Cash in Verlander Deal and Other MLB Trade Rumors
Tigers Would Include Cash in Verlander Deal and Other MLB Trade Rumors
Todd Frazier Trade to Boston Appears to Be Decided
Todd Frazier Trade to Boston Appears to Be Decided
Chicago White Sox Continue Rebuild Without Jose Quintana
Chicago White Sox Continue Rebuild Without Jose Quintana


Leave a Reply

 
© 2006-2017 BBNS.